
P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Loading shareholding data...
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
Om Prakash Manchanda | 30 Apr 2025 | 30 Apr 2025 | 7.89 L | 19,349 | ₹2,802.67 | SELL |
Dr. Lal PathLabs Employees Welfare Trust | 28 Apr 2025 | 30 Apr 2025 | 1.99 L | 25,436 | ₹1,897.14 | SELL |
Om Prakash Manchanda | 28 Apr 2025 | 30 Apr 2025 | 8.08 L | 25,000 | ₹1,930.05 | BUY |
Dr. Lal PathLabs Employees Welfare Trust | 06 May 2025 | 06 May 2025 | 1.83 L | 15,636 | ₹2,136 | SELL |
Om Prakash Manchanda | 06 May 2025 | 06 May 2025 | 7.79 L | 10,157 | ₹2,793.46 | SELL |
Om Prakash Manchanda | 06 May 2025 | 06 May 2025 | 7.94 L | 15,000 | ₹2,174.94 | BUY |
Reena Nakra | 02 May 2025 | 06 May 2025 | 9,989 | 400 | ₹1,930.05 | BUY |
Rahul Sharma | 08 May 2025 | 08 May 2025 | 19,121 | 5,112 | ₹2,832.14 | SELL |
Reena Nakra | 06 May 2025 | 08 May 2025 | 9,289 | 700 | ₹2,810 | SELL |
Om Prakash Manchanda | 09 May 2025 | 09 May 2025 | 7.99 L | 10,000 | ₹2,174.94 | BUY |
Dr. Lal PathLabs Employees Welfare Trust | 09 May 2025 | 09 May 2025 | 1.73 L | 10,000 | ₹2,174.94 | SELL |
Om Prakash Manchanda | 08 May 2025 | 09 May 2025 | 7.89 L | 4,500 | ₹2,891.83 | SELL |
Dr. Lal PathLabs Employees Welfare Trust | 13 May 2025 | 15 May 2025 | 1.73 L | 861 | ₹679.01 | SELL |
Nimish Jindal | 13 May 2025 | 15 May 2025 | 6,175 | 375 | ₹10 | BUY |
Reena Nakra | 21 May 2025 | 22 May 2025 | 9,289 | 300 | ₹2,875 | SELL |
Reena Nakra | 13 May 2025 | 22 May 2025 | 9,589 | 300 | ₹1,930.05 | BUY |
Nimish Jindal | 26 May 2025 | 26 May 2025 | 5,625 | 550 | ₹2,867.04 | SELL |
Dr. Lal PathLabs Employees Welfare Trust | 30 May 2025 | 30 May 2025 | 1.72 L | 500 | ₹1,930.05 | SELL |
Dr. Lal PathLabs Employees Welfare Trust | 30 May 2025 | 30 May 2025 | 3.55 L | 1.84 L | ₹2,281.61 | BUY |
Dr. Lal PathLabs Employees Welfare Trust | 27 May 2025 | 30 May 2025 | 1.72 L | 375 | ₹10 | SELL |
Nimish Jindal | 30 May 2025 | 02 Jun 2025 | 6,600 | 500 | ₹1,930.05 | BUY |
Nimish Jindal | 27 May 2025 | 02 Jun 2025 | 6,100 | 375 | ₹10 | BUY |
Dr. Lal PathLabs Employees Welfare Trust | 05 Jun 2025 | 06 Jun 2025 | 3.55 L | 500 | ₹2,174.94 | SELL |
Nimish Jindal | 05 Jun 2025 | 06 Jun 2025 | 7,000 | 500 | ₹2,174.94 | BUY |
Nimish Jindal | 03 Jun 2025 | 06 Jun 2025 | 6,500 | 100 | ₹2,830 | SELL |
Om Prakash Manchanda | 10 Jun 2025 | 10 Jun 2025 | 7.83 L | 16,336 | ₹2,880.32 | SELL |
PUNIT SHARMA | 16 Jun 2025 | 17 Jun 2025 | - | 186 | ₹2,949.15 | SELL |
PUNIT SHARMA | 12 Jun 2025 | 17 Jun 2025 | 186 | 186 | ₹10 | BUY |
Anupa Dixit | 12 Jun 2025 | 17 Jun 2025 | 1,875 | 625 | ₹10 | BUY |
Dr. Lal PathLabs Employees Welfare Trust | 12 Jun 2025 | 17 Jun 2025 | 3.53 L | 1,689 | ₹308.7 | SELL |
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹1806.27 | +₹159.97 | +9.72% |
| R3 | ₹1738.17 | +₹91.87 | +5.58% |
| R2 | ₹1693.83 | +₹47.53 | +2.89% |
| R1 | ₹1670.07 | +₹23.77 | +1.44% |
| PIVOT | ₹1625.73 | -20.57 | -1.25% |
| CURRENT | ₹1646.30 | - | - |
| S1 | ₹1465.77 | -₹180.53 | -10.97% |
| S2 | ₹1533.87 | -₹112.43 | -6.83% |
| S3 | ₹1557.63 | -₹88.67 | -5.39% |
| S4 | ₹1601.97 | -₹44.33 | -2.69% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
| Company Name |
|---|
Krsnaa Diagnostics Ltd |
Metropolis Healthcare Ltd |
Suraksha Diagnostic Ltd |
Thyrocare Technologies Ltd |
Vijaya Diagnostic Centre Ltd |

Dr. Lal PathLabs Limited is a prominent player in the Indian diagnostic industry, specializing in a comprehensive range of pathological investigations. Founded in 1949 and headquartered in Gurugram, India, the company operates a network of laboratories across the country and internationally, providing a wide array of diagnostic services to both individuals and healthcare institutions. Their services cater to a broad spectrum of medical needs, contributing significantly to disease diagnosis and treatment planning.
The core business of Dr. Lal PathLabs revolves around conducting a diverse range of pathological tests. Their expertise spans several key areas of laboratory medicine, including biochemistry, hematology (the study of blood), histopathology (the examination of tissues), microbiology (the study of microorganisms), electrophoresis (separation of molecules based on size and charge), immunochemistry (the study of chemical reactions involving antibodies), immunology (the study of the immune system), virology (the study of viruses), and cytology (the study of cells). This extensive coverage ensures they can handle a wide array of diagnostic requirements.
Beyond the core diagnostic offerings, Dr. Lal PathLabs also provides radiological investigations, expanding the scope of their services to include imaging techniques. This integrated approach offers healthcare providers a more complete diagnostic picture, potentially improving patient care and treatment efficacy. The company's commitment to quality and comprehensive service delivery is a key factor in their market success.
Further demonstrating a commitment to the medical field beyond direct patient services, Dr. Lal PathLabs also engages in phlebotomist training programs. This initiative addresses the need for skilled phlebotomists, who are essential for accurate and efficient sample collection, thereby contributing to the overall quality of their diagnostic services and supporting the broader healthcare system. This diversification strengthens their position within the healthcare ecosystem.
In summary, Dr. Lal PathLabs Limited is a large-scale diagnostic services provider, offering a vast menu of laboratory investigations and contributing to both clinical practice and the training of essential medical personnel. Their established presence and diverse service portfolio highlight their significant role in the Indian and international healthcare landscape.
12th Floor, Tower B, SAS Tower, Sector 38,, Medicity, Sector-38
Gurgaon
HARYANA
IN
Tel: 911243016500
Website:https://www.lalpathlabs.com/
Group: Health Care Equipment & Services
Sector: Health Care
Industry: Health Care Providers & Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 4,099
IPO Date: 23/12/2015
Dr. Brig. Arvind Lal
Executive Chairman of the Board
Mr. Shankha Banerjee
Chief Executive Officer
Mr. Ved Goel
Group Chief Financial Officer and Chief Executive Officer - International Business
Mr. Jai Meena
Chief Operating Officer
Mr. Manoj Garg
Group Chief Human Resources Officer
Mr. Munender Soperna
Group Chief Information and Digital Officer
Mr. Vinay Gujral
Compliance Officer, Company Secretary
Dr. Vandana Lal
Whole-Time Director
Shri. Arun Duggal
Lead Non-Executive Independent Director
Dr. Archana Erdmann
Non-Executive Director
Mr. Rahul Sharma
Non-Executive Director
Mr. Rohit Bhasin
Non-Executive Independent Director
Get answers to the most common questions about Dr Lal Pathlabs Ltd stock price, fundamentals, financial metrics, and investment analysis